Oliver Tracie 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Oliver Tracie
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-01-04+500→ 70,500 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments, with a commencement date of 1/4/23.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.